Raymond James Financial Services Advisors, Inc. Ionis Pharmaceuticals Inc Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 14,570 shares of IONS stock, worth $523,063. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,570
Previous 15,335
4.99%
Holding current value
$523,063
Previous $730,000
20.14%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding IONS
# of Institutions
404Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$541 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$509 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$371 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$314 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$283 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.1B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...